Sector consensus cbdMD, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:00 2025-01-14 pm EST			5-day change	1st Jan Change
0.5179 ^USD	+6.24%		+4.00%	+38.11%

Dec. 23	CbdMD, Inc. Appoints T. Ronan Kennedy to Its Board of Directors	CI
Dec. 18	CbdMD, Inc., Q4 2024 Earnings Call, Dec 18, 2024

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Divergence of analysts' opinions	Divergence of Target Price	Average Target P.	Ecart obj. / dr	Nbr of analysts
CBDMD, INC.	-	-	2.000	+286.17%	1
ELI LILLY AND COMPANY			984.12	+32.11%	27
NOVO NORDISK A/S			842.55	+42.25%	22
JOHNSON & JOHNSON			171.61	+18.56%	22
ABBVIE INC.			202.33	+15.25%	28
MERCK & CO., INC.			127.05	+27.49%	25
ROCHE HOLDING AG			303.47	+15.21%	18
ASTRAZENECA PLC			174.57	+34.67%	19
NOVARTIS AG			113.75	+15.41%	19
PFIZER, INC.			31.78	+20.32%	23
AMGEN INC.			317.24	+18.77%	26
SANOFI			113.80	+22.05%	21
BRISTOL-MYERS SQUIBB COMPANY			61.01	+9.45%	21
GILEAD SCIENCES, INC.			99.96	+9.84%	26
CHUGAI PHARMACEUTICAL CO., LTD			7,430.00	+9.26%	15
GSK PLC			18.17	+40.46%	18
DAIICHI SANKYO CO., LTD.			6,333.33	+52.35%	18
TAKEDA PHARMACEUTICAL COMPANY LIMITED			4,759.71	+15.50%	17
HALEON PLC			3.980	+8.42%	16
Average			1,162.65	+36.50%	20
Weighted average by Cap.			680.26	+24.69%	23